Join us for our upcoming Awareness Show on Multiple Sclerosis: Early Diagnosis & Holistic Management, powered by Roche. We are honored to have Dr. Neetu Ramrakhiani, Director of Neurology at Fortis Escorts Hospital and a distinguished expert in the field. 📅Date: December 6, 2024 ⏰Time: 5:00 PM Gain valuable insights as Dr. Ramrakhiani highlights the importance of early diagnosis and holistic management of multiple sclerosis, offering strategies to improve care and outcomes. #MultipleSclerosis #Roche #IHWCouncil #Neurology Roche
IHW Council’s Post
More Relevant Posts
-
Join us today for the exciting webinar 📺 on neurodegenerative diseases with leading experts such as Charlotte Teunissen, Nicholas Ashton, Malú Gámez Tansey, Clifford Jack, Giovanni Bellomo, Michael Bartl, Federico Massa, Suzanne Schindler, Katharina B. and our very own Dirk Smeets who will present the science behind #icobrain #aria, the only clinically validated tool to detect and quantify amyloid-related imaging abnormalities (ARIA). Sparked your interest? ⚡ Register while you still can (link below), or check out our recent press release about the market approval of icobrain aria! Video Journal of Neurology (VJNeurology) #vjneurology #Alzheimersdisease #dementia #precisionmedicine
To view or add a comment, sign in
-
🧠 Learning from Multiple Sclerosis to Tackle Parkinson's Disease 🧠 A fantastic perspective from Lorraine Kalia and colleagues in Nature Reviews Neurology highlights the journey of disease-modifying therapies (DMTs) for multiple sclerosis (MS) and what Parkinson’s disease (PD) might learn. While MS has seen ~18 DMTs developed, Parkinson’s still has none. One key to MS’s progress? MRI has been a game-changer for diagnosis and outcome measurement. Key insights: > MS has advanced with imaging tools like MRI—essential for tracking and diagnosing. > Reliable outcome measures for PD and progressive MS are urgent priorities. > Subtyping remains challenging, but it’s crucial for applying the right therapy. This paper inspires us with the possibility of adapting these advancements for PD. It’s a call to action for leveraging imaging and other modalities to better understand early stages, with the hope of one day achieving what MS has in treatment options. Read more about these insights here: https://lnkd.in/eAuGDs5r #ParkinsonsDisease #MultipleSclerosis #DiseaseModifyingTherapies #Neurology #MedicalResearch #Imaging #MRI #HopeForACure #ProgressInScience #KillParkinson
To view or add a comment, sign in
-
🎉 Happy to share that I have successfully completed the online course "An Evidence-Based Approach to the Diagnosis and Management of Migraines in Adults in the Primary Care and General Neurology Setting" from Stanford University! 🎉 This course has equipped me with valuable knowledge and skills to better understand and manage migraines. I’m excited to apply these insights in my practice and continue improving patient outcomes. #ProfessionalDevelopment #Healthcare #Neurology #StanfordUniversity #ContinuousLearning
To view or add a comment, sign in
-
American Academy of Neurology (AAN) 2024 Conference Review has been published by Research Review NZ with expert commentary from Dr Jennifer Pereira (Auckland City Hospital). Our review of the 76th American AAN Annual Meeting, held both in Denver and online, covers many highlights including: the future of ALS, silent vascular lesions: treat or don’t treat, and the current state of long COVID! Read your copy and earn CPD points HERE: https://lnkd.in/gQVSDnEe #longcovid #vascularlesions #research #review #america #academy #neurology
To view or add a comment, sign in
-
We report the study published in the "Journal of Neurology" in collaboration with Professors Umberto Aguglia and Paola Valentino from #DSMC of Università 'Magna Graecia' di Catanzaro. The study analyzed the impact of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) on disability in relapsing multiple sclerosis. The findings indicate that PIRA is the main driver of disability accumulation and is associated with higher long-term disability, highlighting its importance in disease management. Link to the full study:https://lnkd.in/d428iYDP #Neurology
To view or add a comment, sign in
-
"No one really knows the cause of migraine, but a number of studies have begun to piece together the mechanisms behind these headaches from hell. "There's evidence that short strings of amino acids called calcitonin gene-related peptides (CGRP) could be the evil puppeteers behind painful migraine attacks, with treatments targeting CGRP already on the market. There are also signs that malfunctioning fluid drainage systems in the brain might sometimes be involved. "Now, a research team from the University of North Carolina School of Medicine has found evidence that CGRP could be directly involved in blocking the drainage of cerebrospinal fluid from the brain, creating the pressure and pain experienced during migraine." (Science Alert) Find out what makes us Volusia County's highest rated pain and neurology clinic by calling (386) 788-2300 and scheduling a consultation with our experts! #CoastalPainCenter #VolusiaCounty #Pain #ChronicPain #OrmondBeach #OrangeCity #DaytonaBeach #Neurology #PhysicalTherapy #Neuropathy #HeadAches #Migraines #AutoAccident #CarAccident
To view or add a comment, sign in
-
🔍 Explore Top Neurology Conferences: Dive into our latest blog post for a curated list of must-attend events. ➡️Read More: https://bit.ly/4dsdkGJ 🧠Discover the latest in neurology at upcoming conferences that promise cutting-edge insights and networking opportunities! 📅 Save the Dates: Don't miss out on key dates and locations for these pivotal conferences. Check Them Out 🤝 Connect with Experts: Meet and engage with leading professionals in neurology. Learn More 🔗 Enhance Your Practice: Stay ahead with the newest research and developments in neurology. 🚀Stay informed and elevate your expertise. Explore the upcoming neurology conferences today! #PNF #Neurology #HealthcareEvents #CME #CE #ProfessionalDevelopment #MedicalEducation #meded #eMedEvents
To view or add a comment, sign in
-
Are you tuning into the #AANEM this year? We have you covered! Take a look at some of our coverage from AAN so far down below 👇 American Academy of Neurology 🗞️ Riliprubart Demonstrates Favorable Benefit-Risk Profile as Potential Treatment for Chronic Demyelinating Polyneuropathy (https://lnkd.in/eQ7qHPZk) 🗞️ Earlier Initiation of Ublituximab Results In Improved Disease Outcomes in Treatment-Naïve Multiple Sclerosis (https://lnkd.in/ecuxn2iX) 🗞️ Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment (https://lnkd.in/ecsayvrj) Stay tuned for more coverage in #neurology!
To view or add a comment, sign in
-
Let's give a big shoutout to Monika Dominiak, Paweł Mierzejewski, and Anna Z. Antosik for their poster presentation in the upcoming neurology conference on May 6-7, 2024! 🧠 🌐https://lnkd.in/eG4kii-6 Your dedication to advancing knowledge in the field of neurology is truly commendable. Your contributions are invaluable in shaping the future of neurological research and patient care. Wishing you all the best for a successful and insightful conference! #Neurology #Research #Scientexconferences
To view or add a comment, sign in
-
📽️ Our CEO & President, Dr. Daniel Vitt, discusses with Proactive the extended data from our phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis, now published in Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology. Tune in! 🧠 ▶️ https://bit.ly/4dmr8De American Academy of Neurology #Immunic #IMUX #Vidofludimus #IMU838 #EMPhASIS #neurofilament #NfL #RRMS #MultipleSclerosis #MS #MSResearch #ClinicalTrials #Neurology #SciencePublication
To view or add a comment, sign in
11,372 followers